Annual Current Liabilities
$385.40 K
-$792.90 K-67.29%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual total current liabilities is currently $385.40 thousand, with the most recent change of -$792.90 thousand (-67.29%) on 01 December 2023. During the last 3 years, it has risen by +$177.60 thousand (+85.47%). LIPO annual current liabilities is now -67.29% below its all-time high of $1.18 million, reached on 31 December 2022.LIPO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$701.20 K
+$220.90 K+45.99%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly total current liabilities is currently $701.20 thousand, with the most recent change of +$220.90 thousand (+45.99%) on 01 September 2024. Over the past year, it has increased by +$315.80 thousand (+81.94%). LIPO quarterly current liabilities is now -40.49% below its all-time high of $1.18 million, reached on 31 December 2022.LIPO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +81.9% |
| 3 y3 years | +85.5% | +105.9% |
| 5 y5 years | - | - |
LIPO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -67.3% | +85.5% | -40.5% | +134.7% |
| 5 y | 5 years | -67.3% | +85.5% | -40.5% | +134.7% |
| alltime | all time | -67.3% | +85.5% | -40.5% | +134.7% |
Lipella Pharmaceuticals Common Stock Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $701.20 K(+46.0%) |
| June 2024 | - | $480.30 K(-13.0%) |
| Mar 2024 | - | $551.90 K(+43.2%) |
| Dec 2023 | $385.40 K(-67.3%) | $385.40 K(-29.8%) |
| Sept 2023 | - | $548.70 K(+83.6%) |
| June 2023 | - | $298.80 K(-58.3%) |
| Mar 2023 | - | $717.40 K(-39.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.18 M(+245.9%) | $1.18 M(+58.9%) |
| Sept 2022 | - | $741.60 K(+65.6%) |
| June 2022 | - | $447.70 K(+29.3%) |
| Mar 2022 | - | $346.30 K(+1.7%) |
| Dec 2021 | $340.60 K(+63.9%) | - |
| Dec 2021 | - | $340.60 K |
| Dec 2020 | $207.80 K | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual total current liabilities?
- What is the all time high annual current liabilities for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly current liabilities year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual total current liabilities?
The current annual current liabilities of LIPO is $385.40 K
What is the all time high annual current liabilities for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual total current liabilities is $1.18 M
What is Lipella Pharmaceuticals Common Stock quarterly total current liabilities?
The current quarterly current liabilities of LIPO is $701.20 K
What is the all time high quarterly current liabilities for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly total current liabilities is $1.18 M
What is Lipella Pharmaceuticals Common Stock quarterly current liabilities year-on-year change?
Over the past year, LIPO quarterly total current liabilities has changed by +$315.80 K (+81.94%)